Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-K
Source: 0001640334-25-001300
Chunk: 336

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-K
Item: Item 4
Chunk 336
---
 securities) within 60 days of July 15, 2025. None of the named beneficial owners held any options, warrants or convertible securities at July 15, 2025.

Name and Address of Beneficial Owner Amountand NatureofBeneficial Ownership  % of Class        Pao-Chi Chu 2F, No. 356, Dunhua S. Road, Da’an DistTaipei City 106, Taiwan, ROC  30,000,000   49.97%         All officers and directors as a group (one individual)  30,000,000   49.97%

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Related Party Transactions

At December 31, 2024 and 2023, we owed $1,100 to our chief executive officer for non-interest-bearing advances made to us or on our behalf. These advances are due on demand.

During the years ended December 31, 2024 and 2023, a minority stockholder advanced $1,000 and $0, and paid expenses of $35,792 and $9,970 on our behalf, all of which was outstanding on December 31, 2024.

At December 31, 2024 and 2023, we owed $124,488 and $87,696 to the minority stockholder referred to in the preceding paragraph for non-interest-bearing advances made to us or expenses paid on our behalf, respectively. These advances are due on demand.

We have imputed interest at the rate of 4% on the advances made to us or expenses paid on our behalf. Imputed interest amounted to $4,339 and $3,206, during the years ended December 31, 2024 and 2023, respectively.

As of December 31, 2024 and 2023, we had amounts due to related parties of $125,588 and $88,796, respectively.

Director Independence

We have no independent directors.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The following table sets forth the fees billed by KCCW for the year ended December 31, 2024.

  Year EndedDecember 31, 2024 Audit fees $35,000 Audit-related fees  - Tax fees  - 

Audit fees consist of fees related to professional services rendered in connection with the audit and review